JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 23, 2004; DOI: 10.1124/jpet.103.061986


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.061986v1
309/2/804    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yip, L.
Right arrow Articles by Kwok, Y. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yip, L.
Right arrow Articles by Kwok, Y. N.


Received for publication November 6, 2003.
Revised December 24, 2003.
Accepted for publication January 16, 2004.

Role of Adenosine A2A Receptor in the Regulation of Gastric Somatostatin Release

Linda Yip 1 Yin Nam Kwok 1*

1 University of British Columbia

* Address correspondence to: E-mail: kynkwok{at}interchange.ubc.ca

Abstract

Adenosine has been demonstrated to inhibit gastric acid secretion. In the rat stomach, this inhibitory effect may be mediated indirectly by increasing the release of somatostatin-like immunoreactivity (SLI). Results show that adenosine analogs augmented SLI release in the isolated vascularly perfused rat stomach. The rank order of potency of the analogs in stimulating SLI release was 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine (CGS 21680) {approx} 5'-N-ethylcarboxamidoadenosine > 2-chloroadenosine > R(-)-N6-(2-phenylisopropyl)adenosine > 1-deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-N-methyl-{beta}-D-ribofuranuronamide > N6-cyclopentyladenosine {approx} N6-cyclohexyladenosine > S(+)-N6-(2-phenylisopropyl)adenosine, suggesting the involvement of the A2A receptor. In agreement, 4-(2-[7-Amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM 241385), an A2A receptor antagonist, was shown to abolish the adenosine- and CGS 21680-stiumlated SLI release. Immunohistochemical studies revealed the presence of A2A receptor immunoreactivity (A2AR-IR) on the gastric plexi and mucosal D-cells, but not on parietal cells and G-cells, suggesting that adenosine may act directly on D-cells or indirectly on the gastric plexi to augment SLI release. The present study also demonstrates that the structure of the mucosal A2A receptor is identical to that in the rat brain, and that alternative splicing of this gene does not occur. A Real-Time RT-PCR assay has also been established to quantify the levels of A2A receptor mRNA. Results show that gastric tissues contained significantly lower levels of A2A receptor mRNA compared to the striatum. The lowest level was detected in the mucosa. In conclusion, adenosine may act on A2A receptors to augment SLI release and consequently control gastric acid secretion.


Key words: Adenosine, CGS 21680, Real-Time RT-PCR, gastric acid, gastrin, somatostatin


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
L. Yip, H. C. H. Leung, and Y. N. Kwok
Effect of Omeprazole on Gastric Adenosine A1 and A2A Receptor Gene Expression and Function
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 180 - 189.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Yip, H. C. H. Leung, and Y. N. Kwok
Role of Adenosine A1 Receptor in the Regulation of Gastrin Release
J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 477 - 487.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.